7. ADIPOQ генийн -11377C>G полиморфизмын СG генотиптэй хүмүүст сийвэнгийн
адипонектин дааврын түвшин БСХШ-тэй бүлэгт 6.44±3.13 БСХШ-гүй бүлгээс
11.52±11.05 (p=0.017) статистик ач холбогдол бүхий бага байна.
2. БСХШ-тэй бүлэгт инсулин (p<0.013) болон инсулины дөжрөл (p<0.004)
статистик ач холбогдол бүхий өндөр байлаа.
3. PGC-1α генийн Gly482Ser полиморфизмийн GG генотиптэй хүмүүст агшилтын
үеийн цусны даралт их байсан бөгөөд GS болон SS генотиптэй хүмүүстэй
харьцуулахад цусны даралт ихсэх эрсдэл 2.35 дахин их байна (p=0.012). Артерийн
даралт ихсэлттэй, G аллель агуулсан хүмүүст инсулины дөжрөл үүсэх эрсдэл
өндөр байв (r=0.302, p<0.001).
Ном зүй
1. Liu, C. and J.D. Lin, PGC-1 coactivators in the control of energy metabolism.
Acta Biochim Biophys Sin (Shanghai), 2011. 43(4): p. 248-57.
2. Knutti, D. and A. Kralli, PGC-1, a versatile coactivator. Trends Endocrinol Metab,
2001. 12(8): p. 360-5.
3. Ek, J., et al., Mutation analysis of peroxisome proliferator-activated receptor-
gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms
to Type II diabetes mellitus. Diabetologia, 2001. 44(12): p. 2220-6.
4. Esterbauer, H., et al., Human peroxisome proliferator activated receptor gamma
coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal
localization, and tissue expression. Genomics, 1999. 62(1): p. 98-102.
5. Guo, L. and R. Tabrizchi, Peroxisome proliferator-activated receptor gamma as a
drug target in the pathogenesis of insulin resistance. Pharmacol Ther, 2006. 111(1): p.
145-73.
6. Gupta, A.C., et al., Peroxisome proliferators-activated receptor gamma2
Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease
patients. Hepatol Int, 2010. 5(1): p. 575-80.
7. Sookoian, S., et al., Peroxisome proliferator-activated receptor gamma and its
coactivator-1 alpha may be associated with features of the metabolic syndrome in
adolescents. J Mol Endocrinol, 2005. 35(2): p. 373-80.
8. 8. Andrulionyte, L., et al., Common polymorphisms of the PPAR-gamma2
(Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion
from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.
Diabetologia, 2004. 47(12): p. 2176-84.
9. Oberkofler, H., et al., Peroxisome proliferator-activated receptor-gamma
coactivator-1 gene locus: associations with hypertension in middle-aged men.
Hypertension, 2003. 41(2): p. 368-72.
10. Fanelli, M., et al., The Gly482Ser missense mutation of the peroxisome
proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene
associates with reduced insulin sensitivity in normal and glucose-intolerant obese
subjects. Dis Markers, 2005. 21(4): p. 175-80.
11. Iwashima, Y., et al., Hypoadiponectinemia is an independent risk factor for
hypertension. Hypertension, 2004. 43(6): p. 1318-23.
12. Suriyaprom, K., B. Phonrat, and R. Tungtrongchitr, Association of adiponectin
gene -11377C>G polymorphism with adiponectin levels and the metabolic syndrome in
Thais. Asia Pac J Clin Nutr, 2014. 23(1): p. 167-73.
13. Al-Azzam, S.I., et al., The role of adiponectin gene variants in glycemic control in
patients with Type 2 diabetes. Endocr Res, 2014. 39(1): p. 13-7.
14. Du, J., et al., Genetic variants in the ADIPOQ gene and the risk of metabolic
syndrome: a case-control study of a Chinese Han population. Ann Hum Genet, 2012.
76(2): p. 101-9.